307 related articles for article (PubMed ID: 25014890)
1. Biopharmaceutical discovery and production in yeast.
Meehl MA; Stadheim TA
Curr Opin Biotechnol; 2014 Dec; 30():120-7. PubMed ID: 25014890
[TBL] [Abstract][Full Text] [Related]
2. Yeast synthetic biology for the production of recombinant therapeutic proteins.
Kim H; Yoo SJ; Kang HA
FEMS Yeast Res; 2015 Feb; 15(1):1-16. PubMed ID: 25130199
[TBL] [Abstract][Full Text] [Related]
3. Current state-of-the-art in plant-based antibody production systems.
Donini M; Marusic C
Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
[TBL] [Abstract][Full Text] [Related]
4. Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines.
Roohvand F; Shokri M; Abdollahpour-Alitappeh M; Ehsani P
Expert Opin Ther Pat; 2017 Aug; 27(8):929-951. PubMed ID: 28608761
[TBL] [Abstract][Full Text] [Related]
5. Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up.
Madhavan A; Arun KB; Sindhu R; Krishnamoorthy J; Reshmy R; Sirohi R; Pugazhendi A; Awasthi MK; Szakacs G; Binod P
Microb Cell Fact; 2021 Jun; 20(1):124. PubMed ID: 34193127
[TBL] [Abstract][Full Text] [Related]
6. Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.
Berlec A; Strukelj B
J Ind Microbiol Biotechnol; 2013 Apr; 40(3-4):257-74. PubMed ID: 23385853
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation control technologies for recombinant therapeutic proteins.
Gupta SK; Shukla P
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
[TBL] [Abstract][Full Text] [Related]
8. Which yeast species shall I choose? Saccharomyces cerevisiae versus Pichia pastoris (review).
Darby RA; Cartwright SP; Dilworth MV; Bill RM
Methods Mol Biol; 2012; 866():11-23. PubMed ID: 22454110
[TBL] [Abstract][Full Text] [Related]
9. Quality and authenticity of heterologous proteins synthesized in yeast.
Eckart MR; Bussineau CM
Curr Opin Biotechnol; 1996 Oct; 7(5):525-30. PubMed ID: 8939630
[TBL] [Abstract][Full Text] [Related]
10. Emerging trends in production of plant natural products and new-to-nature biopharmaceuticals in yeast.
Perrot T; Marc J; Lezin E; Papon N; Besseau S; Courdavault V
Curr Opin Biotechnol; 2024 Jun; 87():103098. PubMed ID: 38452572
[TBL] [Abstract][Full Text] [Related]
11. The yeast stands alone: the future of protein biologic production.
Love KR; Dalvie NC; Love JC
Curr Opin Biotechnol; 2018 Oct; 53():50-58. PubMed ID: 29277062
[TBL] [Abstract][Full Text] [Related]
12. Yeast as a host for the production of macromolecules of prophylactic or therapeutic interest in human health care.
De Wilde MJ
Bioprocess Technol; 1990; 5():479-504. PubMed ID: 1366491
[No Abstract] [Full Text] [Related]
13. Understanding the yeast host cell response to recombinant membrane protein production.
Bawa Z; Bland CE; Bonander N; Bora N; Cartwright SP; Clare M; Conner MT; Darby RA; Dilworth MV; Holmes WJ; Jamshad M; Routledge SJ; Gross SR; Bill RM
Biochem Soc Trans; 2011 Jun; 39(3):719-23. PubMed ID: 21599640
[TBL] [Abstract][Full Text] [Related]
14. Production of biopharmaceutical proteins by yeast: advances through metabolic engineering.
Nielsen J
Bioengineered; 2013; 4(4):207-11. PubMed ID: 23147168
[TBL] [Abstract][Full Text] [Related]
15. Yeast systems for the expression of heterologous gene products.
Buckholz RG
Curr Opin Biotechnol; 1993 Oct; 4(5):538-42. PubMed ID: 7764203
[TBL] [Abstract][Full Text] [Related]
16. Engineering yeast for producing human glycoproteins: where are we now?
Laukens B; De Visscher C; Callewaert N
Future Microbiol; 2015; 10(1):21-34. PubMed ID: 25598335
[TBL] [Abstract][Full Text] [Related]
17. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
[TBL] [Abstract][Full Text] [Related]
18. Production of recombinant proteins by yeast cells.
Celik E; Calık P
Biotechnol Adv; 2012; 30(5):1108-18. PubMed ID: 21964262
[TBL] [Abstract][Full Text] [Related]
19. The humanization of N-glycosylation pathways in yeast.
Wildt S; Gerngross TU
Nat Rev Microbiol; 2005 Feb; 3(2):119-28. PubMed ID: 15685223
[TBL] [Abstract][Full Text] [Related]
20. Recombinant monoclonal antibody production in yeasts: Challenges and considerations.
Das PK; Sahoo A; Veeranki VD
Int J Biol Macromol; 2024 May; 266(Pt 2):131379. PubMed ID: 38580014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
